Background: Spinopelvic hypermobility may be secondary to a stiff osteoarthritic hip with a compliant spine. Purpose: We sought to determine if spinopelvic hypermobility resolves after total hip arthroplasty (THA) and when it resolves in patients with bilateral hip osteoarthritis (OA) undergoing staged bilateral THA. We also sought to analyze the change in spinopelvic parameters before and after the second THA. Methods: We conducted a retrospective review of 2047 THAs that were performed by 2 fellowship-trained arthroplasty surgeons from 2014 to 2018. Patients with preoperative spinopelvic hypermobility undergoing staged bilateral THA were identified. Radiographic spinopelvic parameters, including sacral slope (SS), pelvic incidence (PI), lumbar lordosis (LL), PI-LL mismatch, anterior pelvic plane tilt (APPt), and spinopelvic tilt (SPT), were measured on preoperative, 6-week postoperative, and 1-year postoperative lateral standing and sitting radiographs. Bilateral hip OA was graded using Kellgren-Lawrence criteria. Results: We identified 42 patients with preoperative spinopelvic hypermobility who underwent staged bilateral THA. Mean time (standard deviation) between surgeries was 9.4 months (±10.0). After the first THA, spinopelvic hypermobility resolved in 29% of the patients. After the second THA, it resolved in 67% at 6 weeks, increasing to 98% at 1 year postoperatively. Conclusion: Spinopelvic hypermobility resolves after staged bilateral THA in 98% of the patients, occurring most often only after the second THA. Less than one-third of the patients had resolution after the first THA, suggesting that contralateral hip OA continues to drive hip-driven spinopelvic motion. Acetabular component position targets based on functional pelvic position should incorporate these changes in spinopelvic motion with the understanding that resolution of hypermobility usually occurs after the second THA.
Background: Spinopelvic hypermobility may be secondary to a stiff osteoarthritic hip with a compliant spine. Purpose: We sought to determine if spinopelvic hypermobility resolves after total hip arthroplasty (THA) and when it resolves in patients with bilateral hip osteoarthritis (OA) undergoing staged bilateral THA. We also sought to analyze the change in spinopelvic parameters before and after the second THA. Methods: We conducted a retrospective review of 2047 THAs that were performed by 2 fellowship-trained arthroplasty surgeons from 2014 to 2018. Patients with preoperative spinopelvic hypermobility undergoing staged bilateral THA were identified. Radiographic spinopelvic parameters, including sacral slope (SS), pelvic incidence (PI), lumbar lordosis (LL), PI-LL mismatch, anterior pelvic plane tilt (APPt), and spinopelvic tilt (SPT), were measured on preoperative, 6-week postoperative, and 1-year postoperative lateral standing and sitting radiographs. Bilateral hip OA was graded using Kellgren-Lawrence criteria. Results: We identified 42 patients with preoperative spinopelvic hypermobility who underwent staged bilateral THA. Mean time (standard deviation) between surgeries was 9.4 months (±10.0). After the first THA, spinopelvic hypermobility resolved in 29% of the patients. After the second THA, it resolved in 67% at 6 weeks, increasing to 98% at 1 year postoperatively. Conclusion: Spinopelvic hypermobility resolves after staged bilateral THA in 98% of the patients, occurring most often only after the second THA. Less than one-third of the patients had resolution after the first THA, suggesting that contralateral hip OA continues to drive hip-driven spinopelvic motion. Acetabular component position targets based on functional pelvic position should incorporate these changes in spinopelvic motion with the understanding that resolution of hypermobility usually occurs after the second THA.
Authors: Christina I Esposito; Kaitlin M Carroll; Peter K Sculco; Douglas E Padgett; Seth A Jerabek; David J Mayman Journal: J Arthroplasty Date: 2017-12-13 Impact factor: 4.757
Authors: Sebastien Parratte; Mark W Pagnano; Krista Coleman-Wood; Kenton R Kaufman; Daniel J Berry Journal: Clin Orthop Relat Res Date: 2008-10-02 Impact factor: 4.176
Authors: Hiroyuki Ike; Lawrence D Dorr; Nicholas Trasolini; Michael Stefl; Braden McKnight; Nathanael Heckmann Journal: J Bone Joint Surg Am Date: 2018-09-19 Impact factor: 5.284
Authors: Joseph D Maratt; Christina I Esposito; Alexander S McLawhorn; Seth A Jerabek; Douglas E Padgett; David J Mayman Journal: J Arthroplasty Date: 2014-10-23 Impact factor: 4.757